(Q38116456)

English

Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders

scientific article published on December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Drug interactions with the newer antiepileptic drugs (AEDs)--Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Philip N Patsalos

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

publication date

1 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1045-1061

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

https://scigraph.springernature.com/pub.10.1007/s40262-013-0088-z

0 references

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of eslicarbazepine acetate on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy women.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pharmacokinetics and drug interactions of eslicarbazepine acetate.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pharmacokinetics and interactions of headache medications, part II: prophylactic treatments

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

A non-randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady-state pharmacokinetics of lamotrigine in patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

The effect of atazanavir and atazanavir/ritonavir on UDP-glucuronosyltransferase using lamotrigine as a phenotypic probe

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pharmacokinetics and tolerability of lamotrigine and olanzapine coadministered to healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Lamotrigine plasma levels reduced by oral contraceptives

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Oral contraceptives reduce lamotrigine plasma levels

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Lamotrigine toxicity secondary to sertraline

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Influence of comedication on serum concentrations of aripiprazole and dehydroaripiprazole

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

The effects of lamotrigine on the pharmacokinetics of lithium

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Possible drug-drug interaction between quetiapine and lamotrigine--evidence from a Swedish TDM database

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Possible oxcarbazepine interaction with cyclosporine serum levels: a single case study

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Neuroleptic malignant syndrome without fever after addition of oxcarbazepine to long-term treatment with amisulpride

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pregabalin pharmacology and its relevance to clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

The effects of ethanol on the pharmacokinetics, pharmacodynamics, safety, and tolerability of ezogabine (retigabine).

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Pharmacokinetic interactions of topiramate

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Posaconazole-induced topiramate toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Topiramate can cause lithium toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Variation in lamotrigine plasma concentrations with hormonal contraceptive monthly cycles in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1007%2FS40262-013-0088-Z

21 January 2018

Hormone Replacement Therapy in Women with Epilepsy: A Randomized, Double-Blind, Placebo-Controlled Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms behind the inhibitory effect of ethanol on the conjugation of morphine in rat hepatocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in tiagabine serum concentration with coadministration of gemfibrozil

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin-felbamate interaction: first report

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Contraceptives Induce Lamotrigine Metabolism: Evidence from a Double-blind, Placebo-controlled Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of eslicarbazepine acetate on the pharmacokinetics of metformin in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23794036

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40262-013-0088-Z

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38116456&oldid=2143836218"